T2 Biosystems (TTOO)

T2 Biosystems (TTOO) Financial Statements


T2 Biosystems Financial Overview

T2 Biosystems's market cap is currently ―. The company's EPS TTM is $-16.493; its P/E ratio is -0.34; T2 Biosystems is scheduled to report earnings on July 31, 2024, and the estimated EPS forecast is $-0.97. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 2.06M$ 1.47M$ 1.96M$ 2.08M$ 5.48M
Gross Profit$ -2.14M$ -2.45M$ -2.90M$ -1.92M$ 1.75M
EBIT$ -12.28M$ -14.31M$ -4.81M$ -16.44M$ -7.75M
EBITDA$ -11.85M$ -13.70M-$ -15.82M$ -7.23M
Net Income Common Stockholders$ -13.53M$ -15.43M$ -6.35M$ -17.96M$ -10.10M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.21M$ 24.30M$ 16.10M$ 10.12M$ 10.33M
Total Assets$ 24.75M$ 43.28M$ 37.13M$ 32.73M$ 34.33M
Total Debt$ 7.83M$ 49.48M$ 59.48M$ 59.35M$ 59.22M
Net Debt$ 1.62M$ 25.18M$ 43.38M$ 49.24M$ 48.89M
Total Liabilities$ 62.53M$ 62.52M$ 73.55M$ 82.62M$ 73.98M
Stockholders Equity$ -37.77M$ -19.20M$ -36.40M$ -49.90M$ -39.70M
Cash Flow-
Free Cash Flow$ -11.68M$ -13.41M-$ -13.02M$ -10.37M
Operating Cash Flow$ -11.68M$ -13.39M$ -12.39M$ -12.90M$ -10.33M
Investing Cash Flow-$ -13.00K$ -33.00K$ -120.00K$ -36.00K
Financing Cash Flow$ 2.20M$ 21.64M$ 18.39M$ 11.85M$ 748.00K
Currency in USD

T2 Biosystems Earnings and Revenue History

T2 Biosystems Debt to Assets

T2 Biosystems Cash Flow

T2 Biosystems Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis